Monoclonal antibodies as drugs.
- Published in:
- Drug Development Research, 2004, v. 61, n. 3, p. 107, doi. 10.1002/ddr.10350
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2004 AND VI 61 AND IP 3
Results: 6
1
2
Design and engineering human forms of monoclonal antibodies.
- Published in:
- Drug Development Research, 2004, v. 61, n. 3, p. 121, doi. 10.1002/ddr.10347
- By:
- Publication type:
- Article
3
The clinical pharmacology of therapeutic monoclonal antibodies.
- Published in:
- Drug Development Research, 2004, v. 61, n. 3, p. 108, doi. 10.1002/ddr.10346
- By:
- Publication type:
- Article
4
Improving monoclonal antibodies for cancer therapy.
- Published in:
- Drug Development Research, 2004, v. 61, n. 3, p. 172, doi. 10.1002/ddr.10345
- By:
- Publication type:
- Article
5
Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies.
- Published in:
- Drug Development Research, 2004, v. 61, n. 3, p. 137, doi. 10.1002/ddr.10344
- By:
- Publication type:
- Article
6
The role of functional genomics in selecting disease targets for antibody‐based therapy.
- Published in:
- Drug Development Research, 2004, v. 61, n. 3, p. 155, doi. 10.1002/ddr.10343
- By:
- Publication type:
- Article